Skip to content
HowShorted

TG THERAPEUTICS, INC. short interest in 2022

In 2022, TG THERAPEUTICS, INC.'s disclosed short interest ran from 11.43% of shares outstanding on 14 Jan 2022 to 16.06% on 30 Dec 2022, a change of +4.63 percentage points. The year's high was 16.06% on 30 Dec 2022 and its low 11.43% on 14 Jan 2022, averaging 13.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.67 days on 28 Feb 2022. Full history: TG THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TG THERAPEUTICS, INC. in 2022

2022 in figures

Start of year
11.43% (14 Jan 2022)
End of year
16.06% (30 Dec 2022)
Change
+4.63 pp
High
16.06% (30 Dec 2022)
Low
11.43% (14 Jan 2022)
Average
13.48%
Highest days to cover
11.67 (28 Feb 2022)
SEC filings marked
7

Every report in 2022

TG THERAPEUTICS, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202211.43%9.06
31 Jan 202211.66%3.62
15 Feb 202213.27%7.32
28 Feb 202213.80%11.67
15 Mar 202213.28%9.8710-K filed, results (8-K)
31 Mar 202214.74%8.52
14 Apr 202213.55%10.90
29 Apr 202213.66%5.06
13 May 202213.68%7.4010-Q filed
31 May 202213.32%6.35
15 Jun 202214.06%4.30
30 Jun 202214.41%5.90
15 Jul 202214.44%7.47
29 Jul 202214.11%8.51
15 Aug 202213.03%5.49results (8-K), 10-Q filed
31 Aug 202212.57%8.13
15 Sep 202212.19%6.78
30 Sep 202212.65%7.17
14 Oct 202213.38%9.29
31 Oct 202213.24%8.22
15 Nov 202213.54%5.1210-Q filed, results (8-K)
30 Nov 202213.32%9.43
15 Dec 202214.23%6.21
30 Dec 202216.06%1.94

See also: TG THERAPEUTICS, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.